Robot-assisted PCI market to reach $149.68B by 2030

The Business Research Company says the robot-assisted percutaneous coronary intervention market will jump from $27.56 billion in 2025 to $38.73 billion in 2026, then reach $149.68 billion by 2030. The report points to rising cardiovascular disease, demand for more precise procedures and broader adoption of robotic systems as the main growth drivers.

Why it matters: - Robot-assisted PCI is moving from a niche technology toward broader use in complex coronary procedures. - The market’s forecast growth points to rising demand for procedures that can improve precision, reduce radiation exposure and support patient safety. - Hospitals and cath labs could face stronger pressure to adopt robotic systems as cardiovascular cases increase.

What happened: - The Business Research Company released a 2026 market report on the global robot-assisted percutaneous coronary intervention market. - The report estimates the market will grow from $27.56 billion in 2025 to $38.73 billion in 2026. - The report projects the market will reach $149.68 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Robot-assisted PCI is a minimally invasive procedure that uses robotic systems to guide catheters, balloons and stents through narrowed or blocked coronary arteries. - The technology is designed to improve precision, stability and control during procedures. - The report links growth to rising coronary artery disease, limits in manual PCI precision, wider use of catheter-based interventions, greater awareness of radiation hazards and expansion of cardiac catheterization labs. - The report also cites advances in robotic intervention technologies, more automation in cardiology, investment in digital healthcare infrastructure and rising demand for complex PCI procedures. - Favorable regulatory approvals for robotic systems are helping adoption. - The report highlights trends toward minimally invasive cardiac procedures, lower radiation exposure for clinicians, greater procedural precision, expanded complex coronary capabilities and improved clinical outcomes. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report’s 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables. - The company also offered a free sample report and full report through the sample request page and the full market report.

Between the lines: - The growth forecast suggests robot-assisted PCI is being positioned as a response to both procedural complexity and clinician safety concerns. - The emphasis on radiation reduction and precision signals a market story that is about workflow and risk management, not only device automation. - The regional split implies the U.S. and Canada are already mature markets, while Asia-Pacific may be earlier in adoption and investment. - The report’s focus on data products such as scoring matrices and dashboards suggests vendors are competing on both technology and market intelligence.

What's next: - Adoption is likely to track future regulatory approvals, hospital capital spending and demand for complex coronary interventions. - The market’s pace will depend on how quickly robotic systems move from specialized centers into broader clinical use. - Continued product development in minimally invasive and automation tools should remain a key theme in the category.

The bottom line: - Robot-assisted PCI is emerging as a fast-growing segment in cardiovascular care, with the strongest demand tied to precision, safety and the rising burden of heart disease.